Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
about
Cdc25B functions as a novel coactivator for the steroid receptorsTranscriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemiaCell cycle regulation of the murine cdc25B promoter: essential role for nuclear factor-Y and a proximal repressor element.A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypesMolecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology.Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosisMolecular characteristics of eight gastric cancer cell lines established in Japan.Small molecule inhibitors of dual specificity protein phosphatases.Dual-specificity phosphatases as targets for antineoplastic agents.Clinical implication of 14-3-3 epsilon expression in gastric cancer.Inhibitors of protein tyrosine phosphatases: next-generation drugs?The therapeutic potential of targeting the cell cycle.Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.Inhibiting transient protein-protein interactions: lessons from the Cdc25 protein tyrosine phosphatases.CDC25 phosphatases in cancer cells: key players? Good targets?Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategiesThe anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cellsNetwork pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatmentInhibitors of Cdc25 phosphatases as anticancer agents: a patent review.YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.Expression of cdc25A and cdc25B proteins in thyroid neoplasms.MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.Inappropriate activation of cyclin-dependent kinases by the phosphatase Cdc25b results in premature mitotic entry and triggers a p53-dependent checkpoint.Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivoCDC 25A gene 263C/T, -350C/T, and -51C/G polymorphisms in breast carcinoma.17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways.Modeling of Cdc25B Dual Specifity Protein Phosphatase Inhibitors: Docking of Ligands and Enzymatic Inhibition Mechanism
P2860
Q24548253-9EFAEE91-86AE-4B42-8C42-D5C55F087FF0Q28478143-C0457520-5CBD-44EC-B946-9B076A14CD1FQ30975349-40227F4C-73CD-4B22-A806-99F0274C2660Q33222512-5B52C258-5801-4917-A5F2-8AFCC4BD3BBFQ33586710-54E5EB10-0185-4A5C-ADD5-829EE4D1590FQ33742739-3E4FE2F7-A9D1-4ACB-A383-070A88A62A56Q33756990-EA01418A-163A-4688-97C9-76CA03781162Q34099128-CD0A1123-1B6C-4FF7-B268-830225E45A41Q34293573-9DC325A0-F8DC-4278-9A2A-6D42A3149EFBQ35013977-E266DA3B-DCAD-4313-A98A-DA18ABD2C2EFQ35872073-06A674A6-5C04-4A0E-9439-BD500371FDE9Q36131111-8CAF9F92-97D9-4BD8-A62B-F2E3D2B7CCFCQ36181206-104177A8-DAF5-4285-86EA-7CF830471A47Q36623508-0FC371E3-DC0E-42B8-87A3-759DCB8DB539Q36731111-8521D929-D7DC-45F6-BDF9-4974535C7852Q36849329-DE231526-9617-4ACF-B4BC-7246518CB343Q36889310-52DFD336-D852-41B7-B238-58C5500B3566Q37055940-B22E988C-8F9E-4837-8606-9BACBB6AE413Q37226138-C12A7874-44E1-4D4E-BE97-B4F7089C8E12Q37694564-BEAE864F-135B-4D4F-B395-52ED0CC12168Q37709154-5788221A-B6C4-4421-A7DA-0B5191B1BA7AQ38283623-57316679-640B-4CD8-B604-A79D41B16703Q38501646-19463460-75A3-41D0-AFE4-04B9753B6D72Q39214217-2381E1E0-A356-452F-B22B-FDC86D045DB5Q39896689-C3C4FCC6-E8B5-4354-A8D0-FC7EE44177C6Q41884226-A8DC6CE0-AFBC-4E77-8393-E0BB55E56185Q46562511-04CCD7D7-A258-4B78-9A45-DB89CE09DFDBQ53628589-C105552C-7180-4744-8B4A-536A30533178Q58855786-38B8863C-6459-4ED4-A0F2-4AD61AA69DF1
P2860
Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@en
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@nl
type
label
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@en
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@nl
prefLabel
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@en
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@nl
P2093
P2860
P1476
Overexpression of cyclin-depen ...... e in human gastric carcinomas.
@en
P2093
H Yokozaki
S Yamamoto
P2860
P304
P356
10.1111/J.1349-7006.1997.TB00313.X
P577
1997-10-01T00:00:00Z